INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2005

Beta-glucan modulates nasal cytokine and eosinophil levels in allergic rhinitis patients.

In a double-blind trial, 24 patients with allergic rhinitis received beta-1,3-1,6-glucan or placebo for 12 weeks. Compared with placebo, glucan treatment significantly decreased nasal lavage levels of IL-4 (p = 0.027) and IL-5 (p = 0.04), while increasing IL-12 (p = 0.008). Nasal lavage eosinophil percentage also decreased significantly in the glucan group (p = 0.01), though peripheral blood eosinophils did not change.

Study type
Randomized controlled trial
Who was studied
24 patients with allergic rhinitis mono-sensitized to Olea europea
What was measured
Nasal lavage cytokines and eosinophil counts

THE PAPER

Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study.

Kirmaz C, Bayrak P, Yilmaz O, Yuksel H. Eur Cytokine Netw, 2005.

PubMed 15941684 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.